Flora Completes Inaugural U.S. Import of CBD Food & Beverage Products from Colombia; Validates New Low-Cost Supply Chain Pathway
-
This represents one of the first-ever exports of CBD containing food and beverage products from
Colombia to the U.S. market. - This export comes as a result of the recent Colombian law change, Resolution 227, that permits the manufacturing and export of food and beverage products that contain non-psychoactive cannabinoids, among other favorable changes.
-
The initial products are from Flora’s Mambe brand and validate the pathway of bringing low-cost non-psychoactive cannabinoid products from
Colombia into theU.S. -
Flora expects to import additional low-cost raw materials and finished product into the
U.S. to be integrated into its supply chain and distribution network, including JustCBD’s extensiveU.S. operations.
Over the coming weeks and months, Flora expects to expand distribution of its CBD-containing food and beverage products, including juices, chocolates, and ghee, among others. Flora will also continue to expand distribution of non-psychoactive flower and derivatives from its Cosechemos cultivation and extraction facility.
“We are thrilled to be the first Colombian cannabis operator to capitalize on the law change
As noted earlier this week, Flora expects to capitalize on multiple synergies relating to its JustCBD acquisition. This includes the global expansion of the JustCBD brand into
You can read more about the JustCBD acquisition on
About
Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands that is designed to deliver one of the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit www.floragrowth.com or follow @floragrowthcorp on social [media] for more information.
Cautionary Statement Concerning Forward-Looking Statements
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: the size of markets for cannabis and cannabis products; the expected and anticipated benefits with respect to Flora’s acquisition of JustCBD, the collaboration with third parties; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220304005085/en/
Investor Relations:
evan.veryard@floragrowth.com
Public Relations:
+1 (858) 264-6600
flora@cmwmedia.com
Source: